254 related articles for article (PubMed ID: 10706706)
1. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation.
Himes SR; Reeves R; Attema J; Nissen M; Li Y; Shannon MF
J Immunol; 2000 Mar; 164(6):3157-68. PubMed ID: 10706706
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter.
González E; Punzón C; González M; Fresno M
J Immunol; 2001 Apr; 166(7):4560-9. PubMed ID: 11254713
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor of activated T cells contributes to the function of the CD28 response region of the granulocyte macrophage-colony stimulating factor promoter.
Shang C; Attema J; Cakouros D; Cockerill PN; Shannon MF
Int Immunol; 1999 Dec; 11(12):1945-56. PubMed ID: 10590260
[TBL] [Abstract][Full Text] [Related]
4. High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters.
Himes SR; Coles LS; Reeves R; Shannon MF
Immunity; 1996 Nov; 5(5):479-89. PubMed ID: 8934574
[TBL] [Abstract][Full Text] [Related]
5. The human IL-2 gene promoter can assemble a positioned nucleosome that becomes remodeled upon T cell activation.
Attema JL; Reeves R; Murray V; Levichkin I; Temple MD; Tremethick DJ; Shannon MF
J Immunol; 2002 Sep; 169(5):2466-76. PubMed ID: 12193716
[TBL] [Abstract][Full Text] [Related]
6. HMG I(Y) interferes with the DNA binding of NF-AT factors and the induction of the interleukin 4 promoter in T cells.
Klein-Hessling S; Schneider G; Heinfling A; Chuvpilo S; Serfling E
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15311-6. PubMed ID: 8986808
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation.
Zhou XY; Yashiro-Ohtani Y; Nakahira M; Park WR; Abe R; Hamaoka T; Naramura M; Gu H; Fujiwara H
J Immunol; 2002 Apr; 168(8):3847-54. PubMed ID: 11937538
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
McGuire KL; Iacobelli M
J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
[TBL] [Abstract][Full Text] [Related]
9. HMGI/Y proteins: flexible regulators of transcription and chromatin structure.
Reeves R; Beckerbauer L
Biochim Biophys Acta; 2001 May; 1519(1-2):13-29. PubMed ID: 11406267
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y).
Brunetti A; Manfioletti G; Chiefari E; Goldfine ID; Foti D
FASEB J; 2001 Feb; 15(2):492-500. PubMed ID: 11156965
[TBL] [Abstract][Full Text] [Related]
11. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS).
Harada Y; Ohgai D; Watanabe R; Okano K; Koiwai O; Tanabe K; Toma H; Altman A; Abe R
J Exp Med; 2003 Jan; 197(2):257-62. PubMed ID: 12538664
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of the HMGI(Y) family of architectural transcription factors.
Reeves R
Environ Health Perspect; 2000 Oct; 108 Suppl 5():803-9. PubMed ID: 11035986
[TBL] [Abstract][Full Text] [Related]
13. Th2-specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter.
Li-Weber M; Salgame P; Hu C; Davydov IV; Laur O; Klevenz S; Krammer PH
J Immunol; 1998 Aug; 161(3):1380-9. PubMed ID: 9686601
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT.
Paliogianni F; Boumpas DT
Cell Immunol; 1996 Jul; 171(1):95-101. PubMed ID: 8660843
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor of activated T cells and AP-1 are insufficient for IL-2 promoter activation: requirement for CD28 up-regulation of RE/AP.
Shapiro VS; Mollenauer MN; Weiss A
J Immunol; 1998 Dec; 161(12):6455-8. PubMed ID: 9862666
[TBL] [Abstract][Full Text] [Related]
16. Hepatic nuclear factor 3 and high mobility group I/Y proteins bind the insulin response element of the insulin-like growth factor-binding protein-1 promoter.
Allander SV; Durham SK; Scheimann AO; Wasserman RM; Suwanichkul A; Powell DR
Endocrinology; 1997 Oct; 138(10):4291-300. PubMed ID: 9322942
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.
Gringhuis SI; de Leij LF; Verschuren EW; Borger P; Vellenga E
Blood; 1997 Oct; 90(7):2690-700. PubMed ID: 9326236
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-kappaB/Rel transcription factors.
Maggirwar SB; Harhaj EW; Sun SC
Mol Cell Biol; 1997 May; 17(5):2605-14. PubMed ID: 9111330
[TBL] [Abstract][Full Text] [Related]
19. Repression of IL-2 promoter activity by the novel basic leucine zipper p21SNFT protein.
Iacobelli M; Wachsman W; McGuire KL
J Immunol; 2000 Jul; 165(2):860-8. PubMed ID: 10878360
[TBL] [Abstract][Full Text] [Related]
20. Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element.
Hedin KE; Bell MP; Kalli KR; Huntoon CJ; Sharp BM; McKean DJ
J Immunol; 1997 Dec; 159(11):5431-40. PubMed ID: 9548483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
